The Cost of FDA Regulations

Richard Epstein discusses the high costs and delays associated with FDA regulations in the drug industry. He argues that the FDA's vigilance often results in unnecessary deaths due to delayed access to therapies available in other countries. Epstein also criticizes the current system of product liability suits, which he believes greatly increases the cost of marketing drugs.